Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration

This analysis suggests that plasma PCSK9 combined with LDL-C concentrations might be useful to predict certain PCSK9 LOF mutations such as the R46L mutation but may fail to predict others such as the InsLEU mutation.